Skip to main content
OpenTrials

Clinical trial condition

Neurofibromatosis Type 1 and Growing or Symptomatic, Inoperable PN

Explore clinical trials studying Neurofibromatosis Type 1 and Growing or Symptomatic, Inoperable PN. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Neurofibromatosis Type 1 and Growing or Symptomatic, Inoperable PN trial results

Completed

MEK Inhibitor PD-0325901 Trial in Adolescents and Adults With NF1

NCT02096471

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +16 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • University of Chicago Chicago, Illinois, United States
  • Indiana Unversity Indianapolis, Indiana, United States
View Trial Details

Related conditions